CORRESP Filing
CITIUS ONCOLOGY, INC.
Date: Sept. 2, 2025 · CIK: 0001851484 · Accession: 0001213900-25-082978
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289979
Letter
CITIUS ONCOLOGY, INC.
11 Commerce Drive, First Floor
Cranford, NJ 07016
September 2, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joshua Gorsky
Re:
Acceleration Request Citius Oncology, Inc. Registration Statement on Form S-3 Filed September 2, 2025 File No. 333-289979
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Citius Oncology, Inc. (the "Registrant") hereby requests that the U.S. Securities and Exchange Commission (the "Commission") take appropriate action to accelerate the effective date of the above-referenced registration statement (the "Registration Statement") so as to become effective on Wednesday, September 3, 2025 at 4:15 p.m. Eastern Time, or as soon thereafter as practicable.
The Registrant hereby authorizes Alexander M. Donaldson, Andrew Gibbons, or Christopher Agoranos of Wyrick Robbins Yates & Ponton LLP to orally modify or withdraw this request for acceleration.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Wyrick Robbins Yates & Ponton LLP, by calling Alexander M. Donaldson or Christopher Agoranos at (919) 781-4000. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Donaldson via email at adonaldson@wyrick.com and Mr. Agoranos via email at cagoranos@wyrick.com.
Very truly yours,
CITIUS ONCOLOGY, INC.
Show Raw Text
CORRESP 1 filename1.htm CITIUS ONCOLOGY, INC. 11 Commerce Drive, First Floor Cranford, NJ 07016 September 2, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Acceleration Request Citius Oncology, Inc. Registration Statement on Form S-3 Filed September 2, 2025 File No. 333-289979 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Citius Oncology, Inc. (the "Registrant") hereby requests that the U.S. Securities and Exchange Commission (the "Commission") take appropriate action to accelerate the effective date of the above-referenced registration statement (the "Registration Statement") so as to become effective on Wednesday, September 3, 2025 at 4:15 p.m. Eastern Time, or as soon thereafter as practicable. The Registrant hereby authorizes Alexander M. Donaldson, Andrew Gibbons, or Christopher Agoranos of Wyrick Robbins Yates & Ponton LLP to orally modify or withdraw this request for acceleration. Once the Registration Statement is effective, please orally confirm the event with our counsel, Wyrick Robbins Yates & Ponton LLP, by calling Alexander M. Donaldson or Christopher Agoranos at (919) 781-4000. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Donaldson via email at adonaldson@wyrick.com and Mr. Agoranos via email at cagoranos@wyrick.com. Very truly yours, CITIUS ONCOLOGY, INC. By: /s/ Leonard Mazur Leonard Mazur Chairman and Chief Executive Officer cc: Alexander M. Donaldson, Wyrick Robbins Yates & Ponton LLP